Correction to: Nature Medicine https://doi.org/10.1038/s41591-021-01499-z, published online 3 September 2021.
In the version of this Article initially published, there was an error in the author affiliations. Specifically, affiliation 27, corresponding to author Carlo Selmi, has been corrected from “Humanitas Research Hospital, Milan, Italy” to read: “Department of Biomedical Sciences, Humanitas University, Milan, Italy & IRCCS Humanitas Research Hospital, Milan, Italy.”
The change has been made to the online version of the Article.
About this article
Cite this article
Kyriazopoulou, E., Poulakou, G., Milionis, H. et al. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med 27, 1850 (2021). https://doi.org/10.1038/s41591-021-01569-2
This article is cited by
Nature Reviews Rheumatology (2022)
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022)
Wiener klinische Wochenschrift (2022)